BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21632683)

  • 1. Clinical correlates of urolithiasis in ankylosing spondylitis.
    Lui NL; Carty A; Haroon N; Shen H; Cook RJ; Inman RD
    J Rheumatol; 2011 Sep; 38(9):1953-6. PubMed ID: 21632683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy.
    Jauregui E; Conner-Spady B; Russell AS; Maksymowych WP
    J Rheumatol; 2004 Dec; 31(12):2422-8. PubMed ID: 15570645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal study of disease activity and functional status in a hospital cohort of patients with ankylosing spondylitis.
    Robertson LP; Davis MJ
    Rheumatology (Oxford); 2004 Dec; 43(12):1565-8. PubMed ID: 15353608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reference centile charts for measures of disease activity, functional impairment, and metrology in ankylosing spondylitis.
    Taylor AL; Balakrishnan C; Calin A
    Arthritis Rheum; 1998 Jun; 41(6):1119-25. PubMed ID: 9627023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine.
    Landewé R; Dougados M; Mielants H; van der Tempel H; van der Heijde D
    Ann Rheum Dis; 2009 Jun; 68(6):863-7. PubMed ID: 18628283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Swedish version of the Bath ankylosing spondylitis disease activity index. Reliability and validity.
    Waldner A; Cronstedt H; Stenström CH
    Scand J Rheumatol Suppl; 1999; 111():10-6. PubMed ID: 10503554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.
    Maksymowych WP; Jhangri GS; Fitzgerald AA; LeClercq S; Chiu P; Yan A; Skeith KJ; Aaron SL; Homik J; Davis P; Sholter D; Russell AS
    Arthritis Rheum; 2002 Mar; 46(3):766-73. PubMed ID: 11920413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Swedish version of the Bath ankylosing spondylitis functional index. Reliability and validity.
    Cronstedt H; Waldner A; Stenström CH
    Scand J Rheumatol Suppl; 1999; 111():1-9. PubMed ID: 10503553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis].
    Grazio S; Grubisić F; Nemcić T; Matijević V; Skala H
    Reumatizam; 2009; 56(2):63-76. PubMed ID: 20429263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Tunisian versions of Bath Ankylosing Spondylitis Functional Index (BASFI) and Disease Activity Index (BASDAI).
    Kchir MM; Hamdi W; Kochbati S; Azzouz D; Daoud L; Saadellaoui K; Ghannouchi MM; Kaffel D; Ben Hamida A; Zouari B
    Tunis Med; 2009 Aug; 87(8):527-30. PubMed ID: 20180357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease.
    Pérez Alamino R; Maldonado Cocco JA; Citera G; Arturi P; Vazquez-Mellado J; Sampaio-Barros PD; Flores D; Burgos-Vargas R; Santos H; Chavez-Corrales JE; Palleiro D; Gutierrez MA; Vieira-Sousa E; Pimentel-Santos FM; Paira S; Berman A; Moreno-Alvarez M; Collantes-Estevez E;
    J Rheumatol; 2011 Aug; 38(8):1656-60. PubMed ID: 21632676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of the minimum clinically important difference for the bath ankylosing spondylitis indices: a prospective study.
    Pavy S; Brophy S; Calin A
    J Rheumatol; 2005 Jan; 32(1):80-5. PubMed ID: 15630730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
    van der Heijde D; Dijkmans B; Geusens P; Sieper J; DeWoody K; Williamson P; Braun J;
    Arthritis Rheum; 2005 Feb; 52(2):582-91. PubMed ID: 15692973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile onset ankylosing spondylitis (JAS) has less severe spinal disease course than adult onset ankylosing spondylitis (AAS): clinical comparison between JAS and AAS in Korea.
    Baek HJ; Shin KC; Lee YJ; Kang SW; Lee EB; Yoo CD; Song YW
    J Rheumatol; 2002 Aug; 29(8):1780-5. PubMed ID: 12180744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis.
    Spoorenberg A; van der Heijde D; de Klerk E; Dougados M; de Vlam K; Mielants H; van der Tempel H; van der Linden S
    J Rheumatol; 1999 Apr; 26(4):961-5. PubMed ID: 10229428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thoracoabdominal motion in ankylosing spondylitis: association with standardised clinical measures and response to therapy.
    Tzelepis GE; Kalliakosta G; Tzioufas AG; Sfikakis PP; Mandros C; Boki KA; Roussos C; Moutsopoulos HM
    Ann Rheum Dis; 2009 Jun; 68(6):966-71. PubMed ID: 18633126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Work status among patients with ankylosing spondylitis in Argentina.
    Marengo MF; Schneeberger EE; Citera G; Cocco JA
    J Clin Rheumatol; 2008 Oct; 14(5):273-7. PubMed ID: 18679137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual function in male patients with ankylosing spondylitis.
    Ozkorumak E; Karkucak M; Civil F; Tiryaki A; Ozden G
    Int J Impot Res; 2011; 23(6):262-7. PubMed ID: 21814226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urolithiasis in ankylosing spondylitis: Correlation with Bath ankylosing spondylitis disease activity index (BASDAI), Bath ankylosing spondylitis functional index (BASFI) and Bath ankylosing spondylitis metrology index (BASMI).
    Fallahi S; Jamshidi AR; Gharibdoost F; Mahmoud MI; Paragomi P; Nicknam MH; Farhadi E; Qorbani M
    Caspian J Intern Med; 2012; 3(4):508-13. PubMed ID: 24009925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index.
    Heuft-Dorenbosch L; van Tubergen A; Spoorenberg A; Landewé R; Dougados M; Mielants H; van der Tempel H; van der Heijde D
    Arthritis Rheum; 2004 Apr; 51(2):154-9. PubMed ID: 15077254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.